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age. In particular, suspected childhood 
TB patients without an identifiable TB 
contact and with normal immune sta-
tus were subjected to further investiga-
tions.  Multidisciplinary  management, 
including enhanced laboratory diagno-
sis of atypical bony lesions in infants 
and children, is recommended for any 
suspected  TB  infection.  Once  BCG-
related infection is confirmed, medical 
treatment has to be consistent. 
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Reemergence  
of Bolivian  
Hemorrhagic Fever,   
2007–2008
To the Editor: Bolivian hemor-
rhagic fever (BHF) was first described 
in  1959  during  outbreaks  affecting 
isolated human communities in east-
ern Bolivia. However, it was not until 
1963 that the etiologic agent, Machupo 
virus, was isolated from the spleen of 
a patient who died from this disease 
(1). Although no cases were reported 
between 1976 and 1993, an outbreak 
occurred in 1994 and sporadic cases 
have been observed since then.
In February and March 2007, at 
least 20 suspected BHF cases (3 fatal) 
were reported to the El Servicio Depar-
tamental de Salud (SEDES) in Beni, 
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Table.	Characteristics	Mycobacterium bovis	BCG	complication	cases,	Taiwan,	2005–2007*	
Patient
no.
Sex/age	at	
diagnosis,	y	 Year	reported	 Specimen Diagnosis	and	site	of	involvement	
1 F/2 2005 Biopsy	sample	 BCG	osteitis/osteomyelitis,	right	ankle	
2 M/1 2005 Bacterial	isolate	 Subcutaneous	abscess,	left	anterior	chest	wall	
3 M/2 2005 Bacterial	isolate	 Severe	combined	immunodeficiency,	disseminated	BCGitis	
4 M/9 2005 Bacterial	isolate	 Suppurative	lymphadenitis	
5 F/1 2005 Bacterial	isolate	 Injection-site	abscess	
6 M/1 2005 Biopsy	sample	 Suppurative	lymphadenitis	
7 M/2 2006 Bacterial	isolate	 BCG	osteitis/osteomyelitis,	right	distal	femoris	
8 M/2 2006 Bacterial	isolate	 BCG	osteitis/osteomyelitis	
9 F/1 2006 Bacterial	isolate	 BCG	osteitis/osteomyelitis,	left	distal	femoris	
10 F/1 2006 Bacterial	isolate	 BCG	osteitis/osteomyelitis,	left	distal	radius	
11 F/2 2007 Bacterial	isolate	 BCG	osteitis/osteomyelitis,	right	knee	
12 M/1 2007 Bacterial	isolate	 Subcutaneous	abscess,	left	wrist	
13 M/2 2007 Biopsy	sample	 BCG	osteitis/osteomyelitis,	right	ankle	
14 F/1 2007 Bacterial	isolate	 Suppurative	lymphadentitis	
15 M/2 2007 Bacterial	isolate	 BCG	osteitis/osteomyelitis,	left	proximal	tibia	
*BCGitis,	disseminated	BCG	infection.	LETTERS
Bolivia. In February 2007, physicians 
at the Hospital Santa Maria Magdale-
na reported 3 male patients (23, 27, 
and 29 years of age), who worked at 
a  ranch  in  Magdalena,  Itenez  Prov-
ince  (13°14′0′′S,  64°12′0′′W).  The 
patients  sought  treatment  for  fever, 
gingivorrhagia, petechiae, nausea, he-
matemesis, melena and tremors; clini-
cal  laboratory  examinations  showed 
thrombocytopenia  (<130,000  cells/
mm3), leukopenia (<3,900 cells/mm3), 
and  hematuria.  Because  physicians 
suspected BHF, patients received sup-
portive  therapy,  including  intrave-
nous hydration, corticoids, antipyretic 
drugs, antimicrobial drugs, and blood 
transfusions from donors who had sur-
vived Machupo virus infection. None-
theless, 2 of the patients died 3 and 4 
days after admission. 
In  February  2008,  at  least  200 
suspected new BHF cases (12 fatal) 
of BHF were reported to SEDES. A 
febrile hemorrhagic illness developed 
in a 19-year-old man from Huacaraje, 
Itenez  Province  (13°33′S,  63°45′W). 
On first examination at the Hospital 
Santa  Maria  Magdalena,  the  patient 
had fever, tremor, gingivorrhagia, pete-
chiae, bruises, asthenia, and anorexia 
and was admitted with a presumptive 
diagnosis of BHF. Despite supportive 
treatment (including administration of 
plasma from a BHF survivor), his con-
dition  worsened;  hematemesis,  mel-
ena, hematochezia, hematuria, anuria, 
respiratory  alkalosis,  and  metabolic 
acidosis  developed  in  the  patient, 
eventually resulting in death. A fifth 
case  was  detected  in  a  46-year-old 
man from San Ramon, Mamore Prov-
ince  (13°17′0′′S,  64°43′0′′W).  A  fe-
brile hemorrhagic illness developed in 
the patient and he was admitted to the 
Hospital German Busch in Trinidad. 
The  patient  recently  had  been  hired 
as a farm worker. When first seen by 
the attending physicians, he had fever, 
thrombocytopenia,  leukopenia,  pete-
chias, tremors, gingivorrhagia, and de-
hydration,  consistent with symptoms 
of BHF. The patient received hydra-
tion,  corticoids,  antipyretic  therapy, 
and a plasma transfusion from a BHF 
survivor. The patient’s condition im-
proved and he was subsequently dis-
charged  from  the  hospital  ≈10  days 
after admission.
Nineteen serum samples collected 
from suspected BHF patients, includ-
ing  the  cases  described  above,  were 
sent to Centro Nacional de Enferme-
dades Tropicales (Santa Cruz, Bolivia) 
and the US Naval Medical Research 
Center Detachment (Lima, Peru) for 
testing. Serum was injected into Vero 
and C6/36 cells; 10 days later, the cells 
were tested for flaviviruses, alphavi-
ruses, and arenaviruses by indirect im-
munofluorescent assay and PCR. Five 
arenavirus isolates were obtained from 
the patients described in this report.
Viral RNA was extracted from the 
cell culture supernatant and the small 
(S) segment (≈3,200 bp) was ampli-
fied  and  sequenced.  Phylogenetic 
analyses  were  conducted  using  the 
neighbor-joining and maximum likeli-
hood program implemented in PAUP 
4.0 software (Sinauer Associates, Inc., 
Sunderland,  MA,  USA).  Sequence 
analyses  confirmed  the  isolates  as 
Machupo virus (Figure). Eight major 
Machupo phylogenetic lineages were 
described based on partial sequence of 
the nucleocapsid protein gene (2). We 
observed a similar tree topology based 
on  the  glycoprotein  gene  sequences 
(Figure). Two  distinct  lineages  were 
distinguished among the isolates from 
the  Itenez  and  Mamore  provinces: 
V and VII and I and II, respectively. 
The recent isolates (2007–2008) from 
Magdalena  and  Huacaraje  (Itenez 
Province)  grouped  within  lineage  V 
whereas  the  2008  isolate  from  San 
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Figure.	Neighbor-joining	phylogenetic	tree	of	Machupo	virus	derived	from	the	glycoprotein	
precursor	gene	sequence.	The	neighbor-joining	and	maximum	likelihood	analyses	yielded	
similar	 phylogenetic	 trees.	 Boldface	 indicates	 2007–2008	 isolates.	 Numbers	 indicate	
bootstrap	values	for	1,000	replicates.	Scale	bar	indicates	nucleotide	substitutions	per	site.LETTERS
Ramon (Mamore Province) belonged 
to  lineage  II. These  isolates  showed 
10% nucleotide difference within the 
S segment and a 6% amino acid dif-
ference  within  the  glycoprotein  pre-
cursor gene. Similar genetic diversity 
has been described with Machupo vi-
rus and other arenaviruses (2–4). Se-
quences generated were deposited in 
GenBank  (accession  nos.  FJ696411, 
FJ696412, FJ696413, FJ696414, and 
FJ696415).
It is not known whether lineage 
VII and I viruses continue to circulate 
or  have  been  replaced  by  lineage V 
and II viruses, respectively. This study 
confirms  the  long-term  maintenance 
of distinct phylogenetically forms of 
Machupo virus in a small area within 
Beni.  Although  the  distribution  of 
the  Machupo  virus  rodent  reservoir 
(Calomys  callosus)  extends  beyond 
the geographic area of the Machupo 
cases described, factors that limit the 
endemic distribution of the virus re-
main unknown. However, population 
differences  among  C.  callosus  may 
account  for  the  natural  nidality  of 
BHF (5). Studies are needed to fully 
identify  and  understand  the  ecology 
of the rodent reservoir and Machupo 
virus transmission.
Machupo virus continues to cause 
sporadic  cases  and  focal  outbreaks 
of  BHF  in  Bolivia.  We  describe  5 
confirmed  human  cases  (3  fatal)  of 
Machupo virus infection in Beni De-
partment,  Bolivia,  an  area  in  which 
BHF is endemic. That all 5 patients 
were farmers suggests their infections 
were  probably  acquired  through  oc-
cupational exposure. Although all the 
patients  received  plasma  transfusion 
from patients who had survived BHF 
infection, 3 patients still died. An early 
diagnosis and the rapid administration 
of  Machupo  immune  plasma  before 
the hemorrhagic phase may increase 
the  chance  of  survival,  as  has  been 
observed with other arenavirus infec-
tions (6–8). 
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Relapsing Fever 
Spirochete in  
Seabird Tick, Japan
To the Editor: Tick-borne relaps-
ing fever (TBRF) is caused by infec-
tion  with  spirochetes  belonging  to 
the genus Borrelia. We previously re-
ported a human case of febrile illness 
suspected  to  be  TBRF  on  the  basis 
of serologic examination results; the 
vector most likely was a genus Carios 
tick that had fed on a seabird colony 
(1). However, surveillance of ticks in 
the area did not identify Borrelia spp. 
in any of the Carios ticks sampled (2). 
In 2007 and 2008, a borreliosis inves-
tigation was conducted on Kutsujima 
Island  (35.71′N,  135.44′E)  because 
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